These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7931217)

  • 1. Modification of cerebral cortical noradrenaline release by chronic inhibition of MAO-A.
    Finberg JP; Pacak K; Goldstein DS; Kopin IJ
    J Neural Transm Suppl; 1994; 41():123-5. PubMed ID: 7931217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex.
    Finberg JP; Pacak K; Kopin IJ; Goldstein DS
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):500-5. PubMed ID: 8391652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
    Finberg JP
    Acta Psychiatr Scand Suppl; 1995; 386():8-13. PubMed ID: 7717096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline-degrading activity of monoamine oxidase is localized in noradrenergic neurons of the locus coeruleus of the rat.
    Hasegawa Y; Hida T; Arai R
    Neurosci Lett; 1999 Apr; 264(1-3):61-4. PubMed ID: 10320014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inhibition of monoamine oxidase reduces noradrenaline release in rat vas deferens and anococcygeus muscle.
    Hovevey-Sion D; Finberg JP
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):70-6. PubMed ID: 3114651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens.
    Pepper JP; Baumann MH; Ayestas M; Rothman RB
    Brain Res Mol Brain Res; 2001 Mar; 87(2):184-9. PubMed ID: 11245920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine.
    De Deurwaerdère P; Binda C; Corne R; Leone C; Valeri A; Valoti M; Ramsay RR; Fall Y; Marco-Contelles J
    ACS Chem Neurosci; 2017 May; 8(5):1026-1035. PubMed ID: 27977122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP; Lamensdorf I; Armoni T
    Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats.
    Kitanaka N; Kitanaka J; Watabe K; Takemura M
    Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat.
    Blinc M; Dernovsek M; Sket D
    Experientia; 1989 Dec; 45(11-12):1099-102. PubMed ID: 2513220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of monoamine oxidase inhibition on the regional cerebral blood flow response to circulating noradrenaline.
    Lasbennes F; Lacombe P; Seylaz J
    Brain Res; 1988 Jun; 454(1-2):205-11. PubMed ID: 3409003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I; Ross SB
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex.
    Twist EC; Mitchell SN; Corn TH; Campbell IC
    Eur J Pharmacol; 1991 Apr; 196(2):157-60. PubMed ID: 1908389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.